Literature DB >> 24705864

Correlation between overexpression of EpCAM in prostate tissues and genesis of androgen-dependent prostate cancer.

Yuan Xu1, Hu Zhao, Jianquan Hou.   

Abstract

The objective of this study was to investigate the role of epithelial cell adhesion molecule (EpCAM) in the genesis and the progress of prostate cancer, especially of castration-resistant prostate cancer. Protein expression of EpCAM in ten pairs of prostate cancer tissues and normal adjacent tissues, plus three cell lines, was examined. Short hairpin RNA (shRNA) interference technique was employed to silence the expression of EpCAM in prostate cancer cell LNCaP and construct a stable transfected cell line. In vitro assay was conducted to analyze the effect of EpCAM expression on the expressions of Androgen receptor (AR), Prostate specific antigen (PSA), and cellular proliferation and invasion. EpCAM was found significantly expressed higher in prostate cancer tissues than in normal adjacent tissues. In three cell lines (DU-145, PC-3, and LNCaP), the expression of EpCAM in LNCaP, androgen-dependent prostate cancer cells, was significantly higher than that in the other two. As EpCAM was silenced in LNCaP, the expression levels of AR and PSA obviously descended, and cellular abilities of proliferation and invasion were obviously inhibited.The overexpression of EpCAM has correlation with the genesis of prostate cancer, especially androgen-dependent prostate cancer. As the expression of AR is facilitated, prostate cancer cells' abilities to proliferate and invade are consequently enhanced.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24705864     DOI: 10.1007/s13277-014-1892-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  22 in total

Review 1.  New and emerging agents for the treatment of castration-resistant prostate cancer.

Authors:  Celestia S Higano; E David Crawford
Journal:  Urol Oncol       Date:  2011 Nov-Dec       Impact factor: 3.498

2.  Impact of the EpCAM expression on biochemical recurrence-free survival in clinically localized prostate cancer.

Authors:  Goran Benko; Borislav Spajić; Božo Krušlin; Davor Tomas
Journal:  Urol Oncol       Date:  2011-04-21       Impact factor: 3.498

Review 3.  Androgen receptor signaling in androgen-refractory prostate cancer.

Authors:  M E Grossmann; H Huang; D J Tindall
Journal:  J Natl Cancer Inst       Date:  2001-11-21       Impact factor: 13.506

Review 4.  Adjuvant therapy of colon cancer.

Authors:  Weijing Sun; Daniel G Haller
Journal:  Semin Oncol       Date:  2005-02       Impact factor: 4.929

Review 5.  Future directions in the treatment of androgen-independent prostate cancer.

Authors:  Daniel P Petrylak
Journal:  Urology       Date:  2005-06       Impact factor: 2.649

6.  High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.

Authors:  Gilbert Spizzo; Philip Went; Stephan Dirnhofer; Peter Obrist; Ronald Simon; Hanspeter Spichtin; Robert Maurer; Urs Metzger; Brida von Castelberg; Rahel Bart; Shanna Stopatschinskaya; Ossi Robert Köchli; Philip Haas; Friedrich Mross; Markus Zuber; Holger Dietrich; Susanne Bischoff; Martina Mirlacher; Guido Sauter; Guenther Gastl
Journal:  Breast Cancer Res Treat       Date:  2004-08       Impact factor: 4.872

Review 7.  Novel immunologic and biologic therapies for breast cancer.

Authors:  J C Gutheil
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

Review 8.  Regulation of androgen receptor signaling in prostate cancer.

Authors:  Scott M Dehm; Donald J Tindall
Journal:  Expert Rev Anticancer Ther       Date:  2005-02       Impact factor: 4.512

9.  A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.

Authors:  Huiwen Hao; Yansen Zhen; Zaicun Wang; Fulin Chen; Xin Xie
Journal:  Cell Biol Int       Date:  2013-04-30       Impact factor: 3.612

Review 10.  Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.

Authors:  Ramez N Eskander; Krishnansu S Tewari
Journal:  Clin Pharmacol       Date:  2013-10-03
View more
  2 in total

1.  A New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic Study.

Authors:  Nisha Puthiyedth; Carlos Riveros; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

2.  A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles.

Authors:  Md Khirul Islam; Parvez Syed; Laura Lehtinen; Janne Leivo; Kamlesh Gidwani; Saara Wittfooth; Kim Pettersson; Urpo Lamminmäki
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.